Clinical Trials Directory

Trials / Completed

CompletedNCT05977270

The Effects of Lifebloom One on Physical Activity After Acquired Brain Injury

Evaluation of the Effects of Lifebloom One on Physical Activity After Acquired Brain Injury: A Single-Case Experimental Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
5 (actual)
Sponsor
Lifebloom · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to evaluate the effects of Lifebloom One in people who have suffered a stroke or a traumatic brain injury. The main questions to be answered are: * Does Lifebloom One allow users to spend more time standing each day? * Does Lifebloom One allow users to improve their balance and gait? Participants will use Lifebloom One during 8 weeks. For each participant, gait and balance are compared either with and without Oxilio or before and after Lifebloom One intervention.

Conditions

Interventions

TypeNameDescription
DEVICELifebloom OneLBO is made of Oxilio, an alternative to wheelchair placement for everyday use.

Timeline

Start date
2023-09-15
Primary completion
2024-08-29
Completion
2024-08-29
First posted
2023-08-04
Last updated
2025-03-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05977270. Inclusion in this directory is not an endorsement.

The Effects of Lifebloom One on Physical Activity After Acquired Brain Injury (NCT05977270) · Clinical Trials Directory